Financials
Income statement
Fiscal date | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total reported revenue | 21.8B | 22.3B | 21.5B | 37.5B |
Cost of revenue | 16.5B | 17.2B | 16.1B | 27.2B |
Gross profit | 5.4B | 5.1B | 5.4B | 10.3B |
Operating expense | ||||
Research & development | 641M | 661M | 639M | 805M |
Selling general and admin | 2.9B | 3.2B | 3.1B | 5.5B |
Other operating expenses | 329M | 501M | 211M | 276M |
Operating income | 1.8B | 1.1B | 1.8B | 4.2B |
Non operating interest income | ||||
Income | 115M | 118M | 130M | 124M |
Expense | 547M | 534M | 345M | 630M |
Other income expense | — | — | — | — |
Pretax income | 1.4B | 715M | 1.6B | 3.7B |
Tax provision | 521M | 477M | 375M | 833M |
Net income | 296M | -1.7B | 2.1B | 2.8B |
Basic EPS | 0.8 | -1.1 | 2.4 | 3.3 |
Diluted EPS | 0.8 | -1.1 | 2.4 | 3.3 |
Basic average shares | 563.2M | 563.2M | 561.3M | 558.1M |
Diluted average shares | 563.2M | 563.2M | 561.3M | 558.1M |
EBITDA | 3.1B | 2.7B | 3.1B | 6.9B |
Net income from continuing op. | 867M | 238M | 1.2B | 2.8B |
Minority interests | 175M | 1.1B | -745M | -1.0B |
Preferred stock dividends | 0 | 0 | 0 | 0 |